Which medication is NOT commonly associated with drug-induced interstitial lung disease (ILD)?

Aspirin is not commonly associated with drug-induced interstitial lung disease (ILD), making it the correct answer in this context. ILD can be caused by a variety of medications, and recognizing which drugs are typically linked to this condition is crucial for diagnosis and management.

Amiodarone is well-known for its potential to cause pulmonary toxicity, which can lead to ILD. Procarbazine, primarily used in cancer chemotherapy, is also associated with lung damage and can result in interstitial lung pathology. Nitrofurantoin, an antibiotic, has been documented to cause pulmonary reactions, including ILD, particularly with long-term use.

In contrast, while aspirin can cause a range of adverse effects, it is not recognized as a medication that induces ILD. This distinction highlights the importance of understanding medication profiles when evaluating respiratory symptoms in patients.